Financial News
FDA approves Pfizer’s first gene therapy for rare inherited bleeding disorder
April 26, 2024 at 07:02 AM EDT
The agency greenlit the drug, which will be marketed as Beqvez, for adults with moderate to severe hemophilia B.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
